To confirm the high expression of IL-32 in bladder cancer, we analyzed data from The Cancer Genome Atlas Program (TCGA) and The Genotype-Tissue Expression Project (GTEx) as previously reported (Tang et al., 2017). The gene discussed is IL32; the disease is urinary bladder carcinoma.